Non- Small Cell Lung Cancer-NSCLC
Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, characterized by slow progression but complex treatment needs.
CureU Healthcare offers state-of-the-art diagnosis and targeted treatments to improve survival and quality of life.
Overview And Clinical Background
Non-Small Cell Lung Cancer comprises multiple subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
It’s linked with smoking, pollution, and genetic predisposition.
- Key point: NSCLC represents about 85% of all lung cancer cases.
- Can remain asymptomatic until advanced stages.
- Third point: Early detection through imaging is critical for effective management.
Symptoms, Signs And Presentation
Patients may show cough, chest pain, or shortness of breath.
Weight loss and fatigue often indicate disease spread.
- Common symptom: Chronic cough or coughing up blood.
- Chest discomfort or recurring pneumonia.
- Red flag: Sudden weight loss or severe breathlessness.
Diagnosis Methods And Investigations
Diagnosis includes imaging, biopsy, and molecular testing for mutations.
Staging determines the extent of disease and guides treatment.
- Imaging: CT scan and PET-CT to detect lesions and metastases.
- Lab tests: Genetic and biomarker studies to guide targeted therapy.
- Bronchoscopy or biopsy confirms histopathology.
Treatment Options And Surgical Techniques
Treatment is tailored to cancer stage, type, and patient condition.
It includes surgery, chemotherapy, radiotherapy, and targeted therapy.
- Conservative: Smoking cessation and symptom management.
- Minimally invasive options: Video-assisted thoracic surgery (VATS) for localized tumors.
- Immunotherapy and targeted drugs for advanced cases.
Recovery, Risks And Prognosis
Recovery depends on disease stage and treatment modality.
Early detection improves outcomes; advanced cases may need long-term care.
Why Choose Us
CureU Healthcare combines advanced oncology expertise, multidisciplinary collaboration, and personalized care for each NSCLC patient.
Focus on comfort, compassion, and cutting-edge results.
Conclusion
With timely intervention and precision medicine, NSCLC can be managed effectively.
CureU Healthcare ensures every patient receives individualized, evidence-based care.
